Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

 Depo-SubQ Provera 104 (Medroxyprogesterone Acetate) Injectable Suspension
Company: Pfizer, Inc.
Application No.:  021583
Approval Date: 02/17/2004

 

Date created: May 09 , 2007

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-